Max Robotics — Global Service Robot Directory + US Certification

About

Yingjie Hu is a leading thoracic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for thoracic and gastrointestinal cancers, particularly non-small cell lung cancer (NSCLC) and low rectal cancer. His major contributions include pioneering comparative studies of robotic-assisted lobectomy versus video-assisted thoracic surgery (VATS) for stage IIB–IIIA NSCLC, demonstrating the safety and efficacy of robotic approaches in complex cases. Hu’s 2019 study on this topic has garnered 74 citations, reflecting its significant impact on surgical practice. He has also advanced intersphincteric resection (ISR) for low rectal cancer, exploring laparoscopic and robotic methods to improve anal preservation. More recently, his 2024 analysis of lymph node dissection quality and early recurrence in robotic versus thoracoscopic lobectomy for stage N1-2 NSCLC, based on eleven years of real-world data from a high-volume center, provides crucial insights into oncologic outcomes. With a cumulative citation count exceeding 90, Hu’s work is highly influential, shaping clinical guidelines and surgical decision-making. His research is notable for its rigorous methodology and practical implications, making him a respected voice in thoracic oncology and minimally invasive surgery.